First Successful Administration of LinearDNA via Lipid Nanoparticles
August 10th, 2022
Tag: James A Hayward
APDN Awarded Extension of Health Services Contract with CUNY
August 9th, 2022
APDN Initiates Validation of PCR-based Monkeypox Diagnostic Test
August 2nd, 2022
Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production
July 22nd, 2022
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
U.S. Gov’t Guidance Permits DNA Traceability, Isotopic Testing as Evidence
June 21st, 2022
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7th, 2022
An interview with Dr. James Hayward, Chairman, President & CEO
March 29th, 2021
5-Year Agreement with Montblanc to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients
July 2nd, 2019